Loading
Sitara Peroxide Limited is a listed company. Its directors and officers file their transactions with PSX (SECP). Between 25 October 2025 and 25 October 2026, 0 insiders published 9 filings.
Open-market activity splits into 7 purchases totalling €659k and 1 sale totalling €287k; 0 insiders sit on the buying side and 0 insiders on the selling side. Taken together, the purchases exceed the sales by €372k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €287k, disclosed on 12 January 2026.
Across the 282 companies tracked on its exchange, the median is 3 filings; at 9 filings, this issuer sits above that mark.
The last purchase on record was published on 12 January 2026, which is 286 days ago. The median gap between a trade and its publication by PSX (SECP) is 4 days. The shorter that gap, the sooner other investors can see what insiders have done.
Every figure here comes from the filings published by PSX (SECP) and describes the past, not future prices; it is not investment advice.
· cache
11 of 11 declarations
Sitara Peroxide Limited is a company engaged in the production of hydrogen peroxide. It operates in the XKAR market.